Annemarie Berger

10.5k total citations
130 papers, 3.7k citations indexed

About

Annemarie Berger is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Annemarie Berger has authored 130 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 67 papers in Infectious Diseases and 46 papers in Hepatology. Recurrent topics in Annemarie Berger's work include Hepatitis C virus research (41 papers), Hepatitis B Virus Studies (40 papers) and HIV Research and Treatment (28 papers). Annemarie Berger is often cited by papers focused on Hepatitis C virus research (41 papers), Hepatitis B Virus Studies (40 papers) and HIV Research and Treatment (28 papers). Annemarie Berger collaborates with scholars based in Germany, Italy and Austria. Annemarie Berger's co-authors include Hans Wilhelm Doerr, Holger F. Rabenau, Bernard Weber, Sandra Ciesek, Martin Stürmer, Wolfgang Preiser, Sebastian Hoehl, Stefan Zeuzem, Jindřich Činátl and Regina Allwinn and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Annemarie Berger

126 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annemarie Berger Germany 35 1.8k 1.7k 995 736 401 130 3.7k
Édouard Tuaillon France 30 1.3k 0.7× 1.3k 0.7× 555 0.6× 547 0.7× 317 0.8× 147 2.9k
Philippa C. Matthews United Kingdom 34 1.6k 0.9× 1.6k 1.0× 951 1.0× 1.0k 1.4× 512 1.3× 141 4.1k
Richard Molenkamp Netherlands 36 1.8k 1.0× 2.8k 1.6× 767 0.8× 148 0.2× 543 1.4× 120 4.5k
Mark Pandori United States 31 964 0.5× 1.8k 1.0× 231 0.2× 1.0k 1.4× 461 1.1× 83 3.3k
Marc Lütgehetmann Germany 40 3.1k 1.7× 1.9k 1.1× 2.7k 2.7× 255 0.3× 736 1.8× 221 5.8k
Fujie Zhang China 30 1.4k 0.8× 3.1k 1.8× 262 0.3× 1.4k 1.9× 296 0.7× 179 4.1k
Brian Custer United States 41 1.8k 1.0× 1.4k 0.8× 753 0.8× 268 0.4× 169 0.4× 222 5.4k
Valeria Ghisetti Italy 29 1.3k 0.7× 868 0.5× 751 0.8× 238 0.3× 195 0.5× 140 2.8k
Joseph Torresi Australia 43 2.2k 1.2× 1.6k 0.9× 2.3k 2.3× 258 0.4× 447 1.1× 145 5.4k
Harald H. Kessler Austria 31 1.7k 0.9× 1.5k 0.9× 821 0.8× 259 0.4× 386 1.0× 157 3.5k

Countries citing papers authored by Annemarie Berger

Since Specialization
Citations

This map shows the geographic impact of Annemarie Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annemarie Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annemarie Berger more than expected).

Fields of papers citing papers by Annemarie Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annemarie Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annemarie Berger. The network helps show where Annemarie Berger may publish in the future.

Co-authorship network of co-authors of Annemarie Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Annemarie Berger. A scholar is included among the top collaborators of Annemarie Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annemarie Berger. Annemarie Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Graf, Christiana, Katharina Grikscheit, Sebastian Hoehl, et al.. (2023). Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis. Journal of Clinical Medicine. 12(9). 3162–3162. 1 indexed citations
3.
4.
Bojková, Denisa, Annemarie Berger, Franziska Holz, et al.. (2021). Infectivity of deceased COVID-19 patients. International Journal of Legal Medicine. 135(5). 2055–2060. 30 indexed citations
5.
Schmidt, Michael, Sebastian Hoehl, Annemarie Berger, et al.. (2020). Novel multiple swab method enables high efficiency in SARS‐CoV ‐2 screenings without loss of sensitivity for screening of a complete population. Transfusion. 60(10). 2441–2447. 23 indexed citations
6.
Hoehl, Sebastian, Barbara Schenk, Sandra Westhaus, et al.. (2020). Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany. Clinical Infectious Diseases. 73(9). e3036–e3041. 10 indexed citations
7.
Eis‐Hübinger, Anna Maria, Mario Hönemann, Jürgen J. Wenzel, et al.. (2020). Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples. Journal of Clinical Virology. 127. 104381–104381. 34 indexed citations
8.
Dobler, Gerhard, Tomas Bergström, Horst Buxmann, et al.. (2020). Tick-borne encephalitis virus (TBEV) infection in pregnancy: Absence of virus transmission to the fetuses despite severe maternal disease – A case study. Ticks and Tick-borne Diseases. 11(5). 101491–101491. 11 indexed citations
9.
Reuschenbach, Miriam, Stephan Baldus, Annemarie Berger, et al.. (2013). Characterization of Squamous Cell Cancers of the Vulvar Anterior Fourchette by Human Papillomavirus, p16INK4a, and p53. Journal of Lower Genital Tract Disease. 17(3). 289–297. 20 indexed citations
10.
Bingold, Tobias M., et al.. (2013). Detection of herpesvirus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract?. Medical Microbiology and Immunology. 202(6). 431–436. 18 indexed citations
11.
Stephan, Christoph, Eva Herrmann, Nils von Hentig, et al.. (2012). Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy. Medical Microbiology and Immunology. 202(2). 117–124. 3 indexed citations
12.
Waidmann, Oliver, Verena Bihrer, Thomas Pleli, et al.. (2011). Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection. Journal of Viral Hepatitis. 19(2). e58–65. 109 indexed citations
13.
Reinheimer, Claudia, Regina Allwinn, & Annemarie Berger. (2011). Hepatitis E: are psychiatric patients on special risk?. Medical Microbiology and Immunology. 201(2). 171–175. 8 indexed citations
14.
Stürmer, Martin, Katrin Zimmermann, Carlos Fritzsche, et al.. (2010). Regional spread of HIV-1 M subtype B in middle-aged patients by random env-C2V4 region sequencing. Medical Microbiology and Immunology. 199(2). 123–128. 6 indexed citations
15.
Kimpel, Janine, Stephen E. Braun, Gang Qiu, et al.. (2010). Survival of the Fittest: Positive Selection of CD4+ T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection. PLoS ONE. 5(8). e12357–e12357. 40 indexed citations
16.
Weber, Bernard, et al.. (2006). Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra. Journal of Virological Methods. 135(1). 109–117. 27 indexed citations
17.
18.
Berger, Annemarie, Wolfgang Preiser, & Hans Wilhelm Doerr. (2001). The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Journal of Clinical Virology. 20(1-2). 23–30. 39 indexed citations
19.
Miller, Veronica, et al.. (1999). Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS. 13(8). 951–956. 114 indexed citations
20.
Berger, Annemarie, M. von Depka Prondzinski, H. W. Doerr, Holger F. Rabenau, & Bernard Weber. (1996). Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. Journal of Medical Virology. 48(4). 339–343. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Édouard Tuaillon Breakdown of academic impact, for papers by Philippa C. Matthews Breakdown of academic impact, for papers by Richard Molenkamp Breakdown of academic impact, for papers by Mark Pandori Breakdown of academic impact, for papers by Marc Lütgehetmann Breakdown of academic impact, for papers by Fujie Zhang Breakdown of academic impact, for papers by Brian Custer Breakdown of academic impact, for papers by Valeria Ghisetti Breakdown of academic impact, for papers by Joseph Torresi Breakdown of academic impact, for papers by Harald H. Kessler
Rankless by CCL
2026